VBI Vaccines Inc., of Cambridge, Mass., raised gross proceeds of about $13.6 million in a now-closed private placement of equity led by Opko Health and Perceptive Advisors, with participation by Arch Venture Partners. The company sold about 3.28 million common shares priced at $4.16 per share. (See BioWorld Today, April 15, 2016.)